Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin
Used against a variety of tumours, doxorubicin (DOX), causes multiple side-effects in patients, especially in high doses required to control tumour growth. A drug delivery system (DDS) was developed to deliver DOX. Through DOX encapsulation into chitosan DDS, novel DOX microparticles (DMPs) were for...
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
Trans Tech Publications, Switzerland
2010
|
| Online Access: | http://hdl.handle.net/20.500.11937/26348 |